Verena Haselmann

Nuclear Death Receptor TRAIL-R2 Inhibits Maturation of Let-7 and Promotes Proliferation of Pancreatic and Other Tumor Cells

Verena Haselmann, Alexandra Kurz, Uwe Bertsch et al. · Gastroenterology · 2013 · 115 citations

Life Sciences, Molecular Biology, Oncology +14

The E3 ligase RNF43 inhibits Wnt signaling downstream of mutated β-catenin by sequestering TCF4 to the nuclear membrane

Anke Loregger, Martina Grandl, Raquel Mejías‐Luque et al. · Science Signaling · 2015 · 76 citations · Full text

Life Sciences, Molecular Biology, Molecular Genetics +15

Results of the first external quality assessment scheme (EQA) for isolation and analysis of circulating tumour DNA (ctDNA)

Verena Haselmann, Parviz Ahmad‐Nejad, Wolf J. Geilenkeuser et al. · Clinical Chemistry and Laboratory Medicine (CCLM) · 2017 · 69 citations

Medicine, Molecular Genetics, Oncology +16

Liquid Profiling of Circulating Tumor DNA in Plasma of Melanoma Patients for Companion Diagnostics and Monitoring of BRAF Inhibitor Therapy

Verena Haselmann, Christoffer Gebhardt, Ingrid Brechtel et al. · Clinical Chemistry · 2018 · 62 citations · Full text

Medicine, Molecular Medicine, Oncology +17

Longitudinal assessment of anti-SARS-CoV-2 antibody dynamics and clinical features following convalescence from a COVID-19 infection

Catharina Gerhards, Margot Thiaucourt, Maximilian Kittel et al. · International Journal of Infectious Diseases · 2021 · 57 citations · Full text

Life Sciences, Immunology, Infectious Diseases +16